Back to Journals » Biologics: Targets and Therapy » Volume 8

Biologics: the role of delivery systems in improved therapy
Authors Škalko-Basnet N
Received 21 December 2013
Accepted for publication 3 February 2014
Published 19 March 2014 Volume 2014:8 Pages 107—114
DOI https://doi.org/10.2147/BTT.S38387
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Nataša Škalko-Basnet
Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø, Tromsø, Norway
Abstract: The beginning of the 21st century saw numerous protein and peptide therapeuticals both on the market and entering the final stages of clinical studies. They represent a new category of biologically originated drugs termed biologics or biologicals. Their main advantages over conventional drugs can be summarized by their high selectivity and potent therapeutic efficacy coupled with limited side effects. In addition, they exhibit more predictable behavior under in vivo conditions. However, up to now most of the formulations of biologics are designed and destined for the parenteral route of administration. As a consequence, many suffer from short plasma half-lives, resulting in their frequent administration and ultimately poor patient compliance. This review represents an attempt to address some of the challenges and promises in the product development of biologics both for parenteral and noninvasive administration. Some of the products currently in the pipeline of pharmaceutical development and corresponding perspectives are discussed in more detail.
Keywords: biologics, drug delivery systems, medical devices
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.